Showing results (1231-1240 of 2,174) with videos related to
Sort By:
Pageof 218
The Journal of Experimental Biology|June 17, 2025
Unsupervised learning reveals rapid gait adaptation after leg loss and regrowth in spidersSuzanne Amador Kane, Brooke L Quinn, Xuanyi Kris Wu, et al.Chemical Communications (Cambridge, England)|June 9, 2025
Design and application of a non-toxic platinum derivative of the metal chelator Dp44mT for use as a long-term stable lysosome trackerNandan Sheernaly, Axel Steinbrueck, Jasmine Ochs, et al.Science (New York, N.Y.)|November 11, 2017
Redox-sensitive alteration of replisome architecture safeguards genome integrityKumar Somyajit, Rajat Gupta, Hana Sedlackova, et al.The Journal of Laboratory and Clinical Medicine|November 1, 1988
The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulinS Mankarious, M Lee, S Fischer, et al.Bioinformatics (Oxford, England)|May 23, 2002
Application of Bayesian decomposition for analysing microarray dataT D Moloshok, R R Klevecz, J D Grant, et al.Lancet (London, England)|January 28, 1978
Immune response after splenectomyJ L Sullivan, H D Ochs, G Schiffman, et al.Parasitology|August 1, 1989
Detection of Trypanosoma congolense and Trypanosoma brucei subspecies by DNA amplification using the polymerase chain reactionD R Moser, G A Cook, D E Ochs, et al.Journal of Anatomy|February 18, 2014
Effects of exogenous surfactant on the non-heart-beating donor lung graft in experimental lung transplantation - a stereological studyGudrun Herrmann, Lars Knudsen, Navid Madershahian, et al.Human Vaccines & Immunotherapeutics|April 28, 2015
Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodiesRoger H Brookes, Marin Ming, Kimberley Williams, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1983
Serial cranial computed-tomography scans in children with leukemia given two different forms of central nervous system therapyJ J Ochs, L S Parvey, J N Whitaker, et al.Pageof 218